Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | Mr. Thomas UllrichIndependent Director | -100,00k | 0,00 | Other Derivative Disposition | - | 75,00k | -57,14% |
| 2026-06-01 | Dr. Keith Michael BarronExecutive Chairman, President & CEO | 1,67M | 216,91k | Achat | 0,13 | 61,25M | 2,80% |
| 2026-04-11 | Dr. Keith Michael BarronExecutive Chairman, President & CEO | -13,39k | 0,00 | Other Derivative Disposition | 0,33 | 2,52M | -0,53% |
| 2026-04-13 | Mr. Jonathan H. KaganIndependent Director | -13,39k | 0,00 | Other Derivative Disposition | 0,33 | 1,20M | -1,10% |
| 2026-04-11 | Nathalie Han Kin SangInitié | -13,39k | 0,00 | Other Derivative Disposition | 0,33 | 1,17M | -1,13% |
| 2026-04-11 | Mr. Thomas UllrichIndependent Director | -13,39k | 0,00 | Other Derivative Disposition | 0,33 | 1,20M | -1,10% |
| 2026-03-31 | Dr. Keith Michael BarronExecutive Chairman, President & CEO | 58,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,15 | 2,54M | 2,34% |
| 2026-03-31 | Nathalie Han Kin SangInitié | 29,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,15 | 1,19M | 2,51% |
| 2026-03-31 | Mr. Thomas UllrichIndependent Director | 58,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,15 | 1,22M | 5,01% |
| 2026-03-31 | Mr. Jonathan H. KaganIndependent Director | 58,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,15 | 1,22M | 5,01% |
| 2026-01-25 | Nathalie Han Kin SangInitié | -200,00k | 0,00 | Other Derivative Disposition | 2,34 | 1,16M | -14,73% |
| 2025-12-31 | Nathalie Han Kin SangInitié | 34,50k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,13 | 1,36M | 2,61% |
| 2025-12-31 | Mr. Thomas UllrichIndependent Director | 34,50k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,13 | 1,16M | 3,07% |
| 2025-12-31 | Mr. Jonathan H. KaganIndependent Director | 34,50k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,13 | 1,16M | 3,07% |
| 2025-12-31 | Dr. Keith Michael BarronExecutive Chairman, President & CEO | 34,50k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,13 | 2,48M | 1,41% |
| 2025-12-05 | Dr. Keith Michael BarronExecutive Chairman, President & CEO | 4,17M | 360,67k | Achat | 0,09 | 59,58M | 7,52% |
| 2025-11-17 | Mr. Jonathan H. KaganIndependent Director | -100,00k | 0,00 | Other Derivative Disposition | 2,50 | 1,12M | -8,18% |
| 2025-11-17 | Ms. Carolyn Ann MuirVP of Corporate Development & Investor Relations and Corporate Secretary | -100,00k | 0,00 | Other Derivative Disposition | 2,50 | 930,00k | -9,71% |
| 2025-11-17 | Dr. Keith Michael BarronExecutive Chairman, President & CEO | -100,00k | 0,00 | Other Derivative Disposition | 2,50 | 2,44M | -3,93% |
| 2025-09-30 | Mr. Thomas UllrichIndependent Director | 42,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,10 | 1,12M | 3,89% |
| 2025-09-30 | Mr. Jonathan H. KaganIndependent Director | 42,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,10 | 1,22M | 3,56% |
| 2025-09-30 | Dr. Keith Michael BarronExecutive Chairman, President & CEO | 42,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,10 | 2,54M | 1,68% |
| 2025-09-30 | Nathalie Han Kin SangInitié | 42,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,10 | 1,32M | 3,28% |
| 2025-08-21 | Dr. Keith Michael BarronExecutive Chairman, President & CEO | 5,74M | 495,88k | Achat | 0,09 | 55,41M | 11,56% |
| 2025-06-30 | Mr. Francisco FreyreCFO | 130,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,17 | 330,00k | 65,00% |
| 2025-06-30 | Mr. Thomas UllrichIndependent Director | 292,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,17 | 1,08M | 37,01% |
| 2025-06-30 | Carolina LassoInitié | 180,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,17 | 430,00k | 72,00% |
| 2025-06-30 | Mr. Jonathan H. KaganIndependent Director | 292,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,17 | 1,18M | 32,85% |
| 2025-06-30 | Dr. Keith Michael BarronExecutive Chairman, President & CEO | 732,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,17 | 2,50M | 41,38% |
| 2025-06-30 | Ms. Carolyn Ann MuirVP of Corporate Development & Investor Relations and Corporate Secretary | 240,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,17 | 1,03M | 30,38% |
| 2025-06-30 | Mr. Jean Paul PallierVP of Exploration | 200,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,17 | 755,00k | 36,04% |
| 2025-06-30 | Nathalie Han Kin SangInitié | 292,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,17 | 1,28M | 29,53% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.